A two drug combination shrank brain tumors in mice
Original title: Targeting hypoxia-driven histone lactylation in myeloid cells synergizes with CD137 agonism to expand effector-like exhausted CD8+ T cells in glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
The treatment was only tested in mice, not in people.
The short version
Two drugs used together shrank brain tumors in mice and helped them live longer.
What was studied. Researchers worked with mice that had glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary, a brain tumor. They tested a low dose of a drug called axitinib along with a second drug that switches on immune cells.
What they found. Low oxygen inside the tumor changed certain immune cells. Those cells then blocked the T cells that fight the tumor. The low dose of axitinib raised oxygen in the tumor and stopped that blocking. Adding the second drug made more tumor fighting T cells grow. The tumors shrank, and the mice lived a long time. In people with glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary, having more of these T cells went along with a longer time free of disease.
What this means, and what it doesn't
What it could mean: This points to a new way to help the immune system fight brain tumors. It gives researchers a reason to test this pair of drugs further. Right now it is a lead, not care you can ask your doctor for.
What it doesn't mean: This does not mean a new treatment is here. The work was done in mice, not in people. No one knows yet if it is safe or helpful for patients. Results in mice often do not hold up in people. It is not a promise of a cure, and it is many years away from everyday care.
Source: PubMed, October 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.